Projects per year
Organization Profile
Organisation profile
With thousands of years of history, the development of Chinese medicine has made a tremendous contribution to the proliferation and prosperity of the nations of China and neighboring countries. Owing to the great breadth and profundity of its theories and proven efficacy, Chinese medicine has become a new focus of attention for scientists all over the world. Committed to both inheritance and innovation in Chinese medicine, the School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) makes full use of modern technologies to conduct innovative research on standardisation of Chinese medicine and integration of Chinese medicine and western medicine, and contributes to the internationalisation of Chinese medicine.
The fundamental research strength of SCM lies in the academic and research experts who comprise the largest research team of Chinese medicine in Hong Kong. Riding on the University's strategy of fostering interdisciplinary research, the experts and researchers of SCM have been conducting innovative research on the traditional discipline of Chinese medicine which aims to discover new knowledge and create novel technologies for translation and application to benefit society, and they have produced very encouraging results on this front. The faculty members of SCM have produced substantial research outputs in international scientific journals and have been granted numerous patent rights from the US, European, the People's Republic of China and Hong Kong. In the results of the Research Assessment Exercise 2014 announced by the University Grants Committee, SCM outshone other institutions in the percentage of four-star rating (world leading) in the field of Chinese medicine. Looking ahead, SCM will continue to work hard and scale new heights in the research field of innovative drug discovery, precision medicine and phenome research based on Chinese medicine.
Fingerprint
Collaborations and top research areas from the last five years
Scholars
-
P. ASTHANA, Dr
- Chinese Medicine - Teaching and Research Division - Research Assistant Professor
Person
-
Kam Wa CHAN, Prof
- Chinese Medicine - Teaching and Research Division - Assistant Professor
- Vincent V.C. Woo Chinese Medicine Clinical Research Institute - Associate Director
Person
-
The Role of Interleukin 24 in Regulating Ocular Inflammation: a Novel Cytokine for the Treatment of Autoimmune Uveitis
CHONG, W. P. (PI)
6/06/25 → 30/11/26
Project: Research project
-
Research on the original and quality evaluation of Styrax
XU, J. (PI)
24/04/25 → 31/08/26
Project: Research project
-
-
A biotin-free diet attenuates the incidence of collagen-induced arthritis and alleviates microbial dysbiosis
Su, X., Li, X., He, X., Zhou, S., Lyu, A. & Cai, Z., 21 Jun 2025, In: Food and Function. 16, 12, p. 4983-4993 11 p.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Abstract A021: Cancer-associated fibroblast-derived CXCL12 as a potential therapeutic target for pancreatic ductal adenocarcinoma immunotherapy
Yang, L., Lu, A. & Li, F., 1 Mar 2025, In: Cancer Research. 85, 5, Supplement, 1 p., A021.Research output: Contribution to journal › Conference article › peer-review
-
Abstract A048: Intracellular DKK1 could play a vital role in promoting triple-negative breast cancer cell proliferation, migration, and invasion
Zhang, Y., Chen, Z., Pan, Y., Sun, M., Liu, Y., Chen, M., Luo, H., Kang, W., Lu, A., Yu, S., Yu, Y., Zhang, G. & Zhang, B., Mar 2025, In: Cancer Research. 85, 5, Supplement, A048.Research output: Contribution to journal › Conference article › peer-review
Prizes
Activities
-
European Journal of Pharmacology (Journal)
LIU, J. (Reviewer)
13 Mar 2025 → 15 Mar 2025Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Phytomedicine (Journal)
LIU, J. (Reviewer)
9 Mar 2025 → 22 Mar 2025Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Materials Today Bio (Journal)
LI, C. (Reviewer)
2025 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
Press/Media
-
Hong Kong Baptist University’s researchers adopting interdisciplinary approach to major health challenges receive accolades
16/12/24
1 Media contribution
Press/Media
-
Press conference on potential of artemisinin derivative in treating human obesity
7/03/24
4 items of Media coverage, 2 Media contributions
Press/Media
-
Student theses
-
A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of MicroRans in osteoclasts
Dang, L. (Author), ZHANG, G. (Supervisor), 29 Apr 2016Student thesis: Master's Thesis
File -
A Material Evidence Base for Investigating the Evolution of Chinese Medicinal Varieties and Cross-cultural Exchange
Brand, E. J. (Author), ZHAO, Z. (Supervisor), 4 Sept 2017Student thesis: Doctoral Thesis
File -
A mechanistic study on the anti-melanoma action of quercetin
Cao, H. (Author), YU, Z. (Supervisor), 18 Feb 2015Student thesis: Doctoral Thesis
File